Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 2/20 | 0.38 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | JAK3 | P52333 | 6/20 | 0.37 |
| ▸ | GFER | P55789 | 2/20 | 0.37 |
| ▸ | ITK | Q08881 | 1/20 | 0.37 |
| ▸ | CCNK | O75909 | 3/20 | 0.37 |
| ▸ | CDK12 | Q9NYV4 | 3/20 | 0.37 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.37 |
| ▸ | CDK2 | P24941 | 2/20 | 0.37 |
| ▸ | CDK7 | P50613 | 2/20 | 0.37 |
| ▸ | CCNH | P51946 | 2/20 | 0.37 |
| ▸ | MNAT1 | P51948 | 2/20 | 0.37 |
| ▸ | JAK2 | O60674 | 2/20 | 0.35 |
| ▸ | JAK1 | P23458 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22405018 | 0.92 | JAK3 (0.42) | EGFRBTKJAK3CCNKCDK12 | |
| SCHEMBL21682732 | 0.86 | JAK2 (0.49) | KMT2AJAK3JAK2JAK1 | |
| SCHEMBL29682469 | 0.83 | USP30 (0.46) | BTK | |
| SCHEMBL377033 | 0.83 | USP30 (0.46) | BTK | |
| SCHEMBL2321911 | 0.78 | JAK3 (0.42) | EGFRBTKJAK3ITKJAK1 | |
| SCHEMBL2320756 | 0.76 | JAK3 (0.43) | EGFRBTKJAK3ITKJAK2 | |
| SCHEMBL22431488 | 0.75 | USP30 (0.48) | BTKCCNA2CDK2JAK1 | |
| SCHEMBL30091793 | 0.75 | USP30 (0.48) | BTKCCNA2CDK2JAK1 | |
| SCHEMBL2317524 | 0.75 | JAK3 (0.41) | EGFRBTKJAK3ITKJAK2 | |
| SCHEMBL27782416 | 0.75 | CCNK (0.50) | EGFRJAK3GFERITKCCNK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8518952-B2 | 6 substituted 2-heterocyclylamino pyrazine compounds as CHK-1 inhibitors | PFIZER INC. (US) | 2013-08-27 | — | — | US | disclosed |
| WO-2010016005-A1 | 6 SUBSTITUTED 2-HETEROCYCLYLAMINO PYRAZINE COMPOUNDS AS CHK-1 INHIBITORS | PFIZER INC. (US) | 2010-02-11 | — | — | WO | disclosed |